Spots Global Cancer Trial Database for platelet transfusion
Every month we try and update this database with for platelet transfusion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Retrospective Descriptive Study of Platelet Transfusion in Patients With Palliative Hematologic Malignancies at the University Hospital of Besançon | NCT03814486 | Platelet Transf... Palliative Care | descriptive | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies | NCT02885038 | Lymphoma Multiple Myelom... Lymphocytic Leu... Hodgkin Disease | Platelet concen... | 18 Years - | Etablissement Français du Sang | |
| Effects of Exercise in Combination With Epoetin Alfa | NCT00577096 | Multiple Myelom... | Epoetin Alfa Exercise Autologous Peri... Red Blood Cell ... Thalidomide Heparin, Low-Mo... Platelet Transf... Melphalan Epoetin Alfa Total Therapy I... Red Blood Cell ... Thalidomide Heparin, Low-Mo... Platelet Transf... Melphalan | - | University of Arkansas | |
| Trial to Reduce Alloimmunization to Platelets (TRAP) | NCT00000589 | Blood Platelets Hematologic Dis... Immunization Leukemia, Myelo... Blood Transfusi... | platelet transf... | 15 Years - 75 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) | NCT02074436 | Hematological M... Thrombocytopeni... | EACA Platelet transf... | 19 Years - | Emory University | |
| Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia | NCT03195010 | Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... B-Cell Non-Hodg... Chronic Lymphoc... Chronic Myeloge... Hematologic and... Hematopoietic C... Myelodysplastic... Primary Myelofi... Secondary Myelo... T-Cell Non-Hodg... Thrombocytopeni... Venous Thromboe... | Platelet Transf... Platelet Transf... | 18 Years - | Fred Hutchinson Cancer Center | |
| PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) | NCT02074436 | Hematological M... Thrombocytopeni... | EACA Platelet transf... | 19 Years - | Emory University | |
| TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia | NCT03136445 | Hematologic Neo... Hemorrhage Hematopoietic S... | Tranexamic acid... Placebo | 18 Years - | NHS Blood and Transplant | |
| Trial to Reduce Alloimmunization to Platelets (TRAP) | NCT00000589 | Blood Platelets Hematologic Dis... Immunization Leukemia, Myelo... Blood Transfusi... | platelet transf... | 15 Years - 75 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Retrospective Descriptive Study of Platelet Transfusion in Patients With Palliative Hematologic Malignancies at the University Hospital of Besançon | NCT03814486 | Platelet Transf... Palliative Care | descriptive | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot | NCT01615146 | Myelodysplastic... Leukemia | Platelet Transf... | 18 Years - | Ottawa Hospital Research Institute | |
| Function of Platelets Used for Transfusions | NCT05038722 | Thrombocytopeni... Hematologic Mal... | Platelet transf... | 18 Years - | Örebro University, Sweden | |
| Effects of Exercise in Combination With Epoetin Alfa | NCT00577096 | Multiple Myelom... | Epoetin Alfa Exercise Autologous Peri... Red Blood Cell ... Thalidomide Heparin, Low-Mo... Platelet Transf... Melphalan Epoetin Alfa Total Therapy I... Red Blood Cell ... Thalidomide Heparin, Low-Mo... Platelet Transf... Melphalan | - | University of Arkansas | |
| Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies | NCT02885038 | Lymphoma Multiple Myelom... Lymphocytic Leu... Hodgkin Disease | Platelet concen... | 18 Years - | Etablissement Français du Sang | |
| Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ) | NCT03806712 | Platelet Transf... Hematological M... Palliative Care | multi method qu... | 18 Years - 100 Years | Centre Hospitalier Universitaire de Besancon | |
| Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies | NCT02885038 | Lymphoma Multiple Myelom... Lymphocytic Leu... Hodgkin Disease | Platelet concen... | 18 Years - | Etablissement Français du Sang |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
